Get the Stockscreener App
1.478
4.65%
-0.072
After Hours:
1.47
-0.008
-0.54%
China Sxt Pharmaceuticals Inc stock is traded at $1.478, with a volume of 58,357.
It is down -4.65% in the last 24 hours and up +5.57% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$1.55
Open:
$1.5
24h Volume:
58,357
Relative Volume:
0.19
Market Cap:
$171.49M
Revenue:
$1.93M
Net Income/Loss:
$-3.10M
P/E Ratio:
-0.0903
EPS:
-16.3657
Net Cash Flow:
$-1.93M
1W Performance:
-9.88%
1M Performance:
+5.57%
6M Performance:
-44.44%
1Y Performance:
-67.53%
1-Day Range:
$1.42
$1.59
1-Week Range:
$1.42
$1.68
52-Week Range:
$0.95
$7.84
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.478 | 179.84M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
Is it time to cut losses on China SXT Pharmaceuticals Inc.Dividend Hike & Daily Entry Point Trade Alerts - newser.com
Comparing China SXT Pharmaceuticals Inc. in custom built stock radarsJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Exit strategy if you’re trapped in China SXT Pharmaceuticals Inc.Market Trend Summary & Stepwise Swing Trade Plans - newser.com
China SXT Pharmaceuticals (NASDAQ:SXTC) Given "Sell (E+)" Rating at Weiss Ratings - MarketBeat
Is China SXT Pharmaceuticals Inc. building a consolidation baseProduct Launch & Low Drawdown Momentum Trade Ideas - newser.com
Why China SXT Pharmaceuticals Inc. (2RY) stock attracts HNW investorsJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - newser.com
How buyback programs support China SXT Pharmaceuticals Inc. (2RY) stockJuly 2025 Gainers & Free Real-Time Volume Trigger Notifications - newser.com
Is China SXT Pharmaceuticals Inc. (2RY) stock bottoming after sell offPortfolio Return Summary & Low Risk Growth Stock Ideas - newser.com
Is Assertio Holdings Inc a good long term investmentDividend Reinvestment Plans & Outstanding Portfolio Growth - earlytimes.in
How China SXT Pharmaceuticals Inc. (2RY) stock compares with top peers2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
Real time social sentiment graph for China SXT Pharmaceuticals Inc.Quarterly Profit Review & Reliable Price Action Trade Plans - newser.com
What drives China SXT Pharmaceuticals Inc stock priceRisk Mitigation Techniques & Free ETF and Mutual Fund Comparisons - earlytimes.in
Earnings visualization tools for China SXT Pharmaceuticals Inc.Market Risk Analysis & Consistent Return Strategy Ideas - newser.com
How buybacks impact China SXT Pharmaceuticals Inc. stock valueMarket Sentiment Report & Short-Term High Return Strategies - newser.com
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update - Defense World
Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Expands By 607.4% - MarketBeat
What analysts say about China SXT Pharmaceuticals Inc 2RY stockMorning Star Patterns & Big Profit Low Investment - earlytimes.in
How The Progressive Corporation (PGV) stock expands through international markets2025 Key Highlights & Entry Point Confirmation Alerts - newser.com
Is MCBS stock recession proofMarket Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Why global investors buy Luckin Coffee Inc. (Common Stock) (LC0A) stockWeekly Market Outlook & Stock Portfolio Risk Control - newser.com
Is WEAT stock cheap by valuation metrics2025 Price Momentum & Low Risk Entry Point Guides - newser.com
Will Schneider Electric Infrastructure Limited Stock Go Up in YEAR Price Prediction InsightsTechnology Stock Trends & Watch and Learn From Live Trades - earlytimes.in
Order flow analysis tools used on ADC Therapeutics SA2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com
Will QD stock beat revenue estimates2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com
How moving averages guide PSA.PRF tradingJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Applying big data sentiment scoring on Cardiol Therapeutics Inc.M&A Rumor & High Conviction Trade Alerts - newser.com
How Banca Profilo S.p.A. (BPA) stock compares with tech leadersEarnings Overview Report & Real-Time Buy Zone Alerts - newser.com
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):